ici 118551 has been researched along with Intraocular Pressure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nathanson, JA | 1 |
| Chen, J; Padillo, E; Ruiz, G; Woodward, DF | 1 |
2 other study(ies) available for ici 118551 and Intraocular Pressure
| Article | Year |
|---|---|
ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.
Topics: Adenylyl Cyclase Inhibitors; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Ciliary Body; Heart Rate; In Vitro Techniques; Intraocular Pressure; Isoproterenol; Lung; Propanolamines; Rabbits; Receptors, Adrenergic, beta; Timolol | 1984 |
Pharmacological characterization of beta-adrenoceptor subtype involvement in the ocular hypotensive response to beta-adrenergic stimulation.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Female; Intraocular Pressure; Isoproterenol; Male; Pindolol; Propanolamines; Rabbits; Receptors, Adrenergic, beta; Time Factors; Timolol | 1986 |